The Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, today announced it has received positive interest on opportunities in the UAE from the international life sciences industry during its participation at the BioKorea 2010 Conference and Exhibition in Seoul.
DuBiotech showcased its offerings to the international community at the fifth edition of Korea's largest exhibition and conference on biotechnology that was held from 1-3 September at the Korea Exhibition Center.
Organised by Korea International Trade Association (KITA) and Korea Health Industry Development Institute (KHIDI), the event provided a platform for decision makers from the life sciences sector as well as policy makers and government officials to explore potential collaborations, partnership and investment opportunities.
Marwan Abdulaziz, Director of Business Development for DuBiotech, said: "DuBiotech's ambition is to become the hub for life sciences in the Middle East and gain international recognition for excellence. It is therefore important to be represented at key international industry events such as BioKorea as industry developments in that country present opportunities for DuBiotech and our business partners.
"From our first-time participation in BioKorea, we found that the country is committed to developing its USD2.5-billion biotechnology sector, as well as encouraging international opportunities for Korean firms. By presenting the progress of DuBiotech and the 70 national and international companies that are part of the life sciences park, we successfully raised awareness amongst key stakeholders about DuBiotech and the strategic importance of Dubai as a gateway to a wider market of 1.8 billion people."
BioKorea 2010 included 17 tracks and 50 sessions on topics related to academic and professional experience of experts from within and outside South Korea.
In line with its philosophy to be the major life science hub in the Middle East, DuBiotech has rapidly grown into a community of biotechnology, pharmaceutical, laboratory equipments companies and testing laboratories, including global leaders like Pfizer, Amgen, Merck Serono and Genzyme, in addition to many small and medium businesses.
